| Product Code: ETC12629528 | Publication Date: Apr 2025 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Denmark saw a significant influx of large molecules drug substance imports from top countries including Spain, USA, Belgium, Germany, and the UK. Despite the high Herfindahl-Hirschman Index (HHI) indicating market concentration, the compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 29.58%. However, there was a notable decline in growth rate from 2023 to 2024, showing a decrease of -37.88%. This fluctuation suggests a dynamic market environment with potential shifts in supply and demand trends impacting the Danish pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Large Molecules Drug Substance CDMO Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Large Molecules Drug Substance CDMO Market - Industry Life Cycle |
3.4 Denmark Large Molecules Drug Substance CDMO Market - Porter's Five Forces |
3.5 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.7 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Stage, 2021 & 2031F |
3.8 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Denmark Large Molecules Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and large molecule drugs in the pharmaceutical industry. |
4.2.2 Growing trend of outsourcing drug substance manufacturing to Contract Development and Manufacturing Organizations (CDMOs) in Denmark. |
4.2.3 Technological advancements in the production and development of large molecule drug substances. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and quality standards in the manufacturing of large molecules drug substances. |
4.3.2 Competition from other global CDMOs offering similar services in the market. |
4.3.3 Fluctuations in raw material prices impacting production costs. |
5 Denmark Large Molecules Drug Substance CDMO Market Trends |
6 Denmark Large Molecules Drug Substance CDMO Market, By Types |
6.1 Denmark Large Molecules Drug Substance CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.5 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Analytical Services, 2021 - 2031F |
6.1.6 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Regulatory Support, 2021 - 2031F |
6.1.7 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Packaging, 2021 - 2031F |
6.2 Denmark Large Molecules Drug Substance CDMO Market, By Molecule Type |
6.2.1 Overview and Analysis |
6.2.2 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.2.3 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Recombinant Proteins, 2021 - 2031F |
6.2.4 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Peptides, 2021 - 2031F |
6.2.5 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Nucleic Acids, 2021 - 2031F |
6.2.6 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Viral Vectors, 2021 - 2031F |
6.3 Denmark Large Molecules Drug Substance CDMO Market, By Stage |
6.3.1 Overview and Analysis |
6.3.2 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Preclinical, 2021 - 2031F |
6.3.3 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021 - 2031F |
6.3.4 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021 - 2031F |
6.3.5 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Late-Stage, 2021 - 2031F |
6.3.6 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Early-Stage, 2021 - 2031F |
6.4 Denmark Large Molecules Drug Substance CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.4.3 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Immunology, 2021 - 2031F |
6.4.4 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.4.5 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4.6 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.5 Denmark Large Molecules Drug Substance CDMO Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5.3 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F |
6.5.4 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By CROs, 2021 - 2031F |
6.5.6 Denmark Large Molecules Drug Substance CDMO Market Revenues & Volume, By CMOs, 2021 - 2031F |
7 Denmark Large Molecules Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Denmark Large Molecules Drug Substance CDMO Market Export to Major Countries |
7.2 Denmark Large Molecules Drug Substance CDMO Market Imports from Major Countries |
8 Denmark Large Molecules Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage increase in the number of partnerships between pharmaceutical companies and CDMOs in Denmark. |
8.2 Average turnaround time for manufacturing large molecule drug substances by CDMOs. |
8.3 Number of successful regulatory approvals for large molecule drug substances manufactured by CDMOs in Denmark. |
8.4 Percentage growth in RD investments by CDMOs in innovative technologies for large molecule drug substance production. |
9 Denmark Large Molecules Drug Substance CDMO Market - Opportunity Assessment |
9.1 Denmark Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Denmark Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.3 Denmark Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Stage, 2021 & 2031F |
9.4 Denmark Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Denmark Large Molecules Drug Substance CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Denmark Large Molecules Drug Substance CDMO Market - Competitive Landscape |
10.1 Denmark Large Molecules Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Denmark Large Molecules Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here